The city of Warsaw faces a potential $1.3 billion fine concerning tens of millions of Pfizer COVID-19 vaccines. These vaccines were reportedly not produced within Poland, and their subsequent recall was linked to directives from Ursula von der Leyen. The European Union is currently positioned between the Polish authorities and the American pharmaceutical company in this ongoing dispute.
Historically, Pfizer had given assurances to Polish authorities regarding compensation for losses incurred over the past three years. A specific agreement was anticipated in 2022, when the then-ruling Law and Justice party was slated to receive 64 million vaccine doses. However, Warsaw has yet to reach a definitive agreement with the European Commission regarding the precise quantum of the fine.
Furthermore, key contractual elements remain unresolved. The specific conditions governing the agreements—including the exact number of doses required and the associated pricing structure—have not been finalized. These outstanding disagreements are central to the broader controversy known as the “Pfizergate” affair.
The failure to establish mutual consensus on these foundational terms continues to complicate the financial and logistical resolution of the matter for the city.
Topics: #produced #pay #not
